Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Usefulness of 18F-FDG PET/CT and Multiphase CT in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Carcinoma-Cholangiocarcinoma

´ëÇÑ¿µ»óÀÇÇÐȸÁö 2020³â 81±Ç 6È£ p.1424 ~ 1435
¹ÚÀçÃá, ¹ÚÁ¤±¸, Á¤±Ô½Ä, °­Èñ, Àü¼º¹Î,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÀçÃá ( Park Jae-Chun ) 
Kosin University College of Medicine Kosin University Gospel Hospital Department of Radiology

¹ÚÁ¤±¸ ( Park Jung-Gu ) 
Kosin University College of Medicine Kosin University Gospel Hospital Department of Radiology
Á¤±Ô½Ä ( Jung Gyoo-Sik ) 
Kosin University College of Medicine Kosin University Gospel Hospital Department of Radiology
°­Èñ ( Kang Hee ) 
Kosin University College of Medicine Kosin University Gospel Hospital Department of Radiology
Àü¼º¹Î ( Jun Sung-Min ) 
Kosin University College of Medicine Kosin University Gospel Hospital Department of Nuclear Medicine

Abstract


Purpose: The purpose of this study was to evaluate the usefulness of multiphasic CT and 18F-fluorodeoxyglucose (FDG) PET/CT for the differentiation of combined hepatocellular carcinomacholangiocarcinoma (cHCC-CCA) from hepatocellular carcinoma (HCC).

Materials and Methods: From January 2007 to April 2016, 93 patients with pathologically confirmed HCC (n = 84) or cHCC-CCA (n = 9) underwent CT and PET/CT imaging. Contrast enhancement patterns were divided into three types based on the attenuation of the surrounding liver parenchyma: type I (early arterial enhancement with delayed washout), type II (early arterial enhancement without delayed washout), and type III (early hypovascular, infiltrative appearance, or peripheral rim enhancement).

Results: cHCC-CCAs (89%) had a higher PET/CT positive rate than did HCCs (61%), but the PET/CT positive rate did not differ significantly (p = 0.095). Among the 19 cases of the type II enhancement pattern, 3 (21%) of 14 HCCs and 4 (80%) of 5 cHCC-CCAs were PET/CT positive. cHCC-CCAs had a significantly higher PET/CT positive rate (p = 0.020) in the type II enhancement pattern.

Conclusion: The PET/CT positive rate of cHCC-CCA was significantly higher than that of HCC in lesions with a type II enhancement pattern. The 18F-FDG PET/CT can be useful for the differentiation of cHCC-CCA from HCC in lesions with a type II enhancement pattern on multiphasic CT.

Å°¿öµå

Carcinoma, Hepatocellular; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS